Skip to main content

Advertisement

Table 2 Complete blood count and PT and aPTT of the healthy volunteers and patient groups

From: Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity

  Healthy volunteers Sepsis CTS-TXA Cirrhotic liver disease Pregnancy
Hb (mmol/L) 9.0 (8.4–9.6) 6.0* (5.6–6.3) 6.2* (5.7–6.7) 7.7* (7.2–8.4) 7.8* (7.0–8.4)
Ht (L/L) 0.43 (0.40–0.45) 0.29* (0.27–0.31) 0.29* (0.26–0.32) 0.38* (0.34–0.39) 0.36* (0.34–0.39)
PLT (x109/L) 178 (139–212) 141 (95–213) 101* (91–140) 99* (62–136) 202 (127–234)
WBC (x109/L) 6.4 (5.4–7.9) 20.1* (11.5–25.3) 10.7* (8.3–12.4) 5.0 (4.0–7.5) 10.7* (9.3–11.7)
PT (s) 10.5 (10.2–10.8) 11.5* (10.7–12.1) 11.8* (11.5–12.4) 13.3* (13.0–13.5) 9.6* (9.3–9.6)
aPTT (s) 27 (26–27) 33.5* (30–42.5) 30* (28–33) 29* (29–34) 25* (23–25)
  1. Results are median (IQR); * p < 0.05 in comparison to healthy volunteers
  2. Hb Hemoglobin, Ht Hmatocrit, PLT Platelet count, WBC White blood cell count, PT Prothrombin time, aPTT Activated partial thromboplastin time IQR, Interquartile ranges, CTS-TXA, Cardiothoracic surgery patients using tranexamic acid